ATE215377T1 - Pulver zur nasalen verabreichung peptidischer oder proteinischer arzneistoffe - Google Patents

Pulver zur nasalen verabreichung peptidischer oder proteinischer arzneistoffe

Info

Publication number
ATE215377T1
ATE215377T1 AT94921840T AT94921840T ATE215377T1 AT E215377 T1 ATE215377 T1 AT E215377T1 AT 94921840 T AT94921840 T AT 94921840T AT 94921840 T AT94921840 T AT 94921840T AT E215377 T1 ATE215377 T1 AT E215377T1
Authority
AT
Austria
Prior art keywords
peptidic
powder
nasal administration
proteinic drugs
proteinic
Prior art date
Application number
AT94921840T
Other languages
English (en)
Inventor
Masahiko Dohi
Yoshihisa Nishibe
Yuji Makino
Yoshiki Suzuki
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of ATE215377T1 publication Critical patent/ATE215377T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60H—ARRANGEMENTS OF HEATING, COOLING, VENTILATING OR OTHER AIR-TREATING DEVICES SPECIALLY ADAPTED FOR PASSENGER OR GOODS SPACES OF VEHICLES
    • B60H1/00—Heating, cooling or ventilating devices
    • B60H1/00485—Valves for air-conditioning devices, e.g. thermostatic valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT94921840T 1993-07-30 1994-07-29 Pulver zur nasalen verabreichung peptidischer oder proteinischer arzneistoffe ATE215377T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP20692293 1993-07-30
JP23584193 1993-08-30
JP164494 1994-01-12
PCT/JP1994/001257 WO1995003818A1 (en) 1993-07-30 1994-07-29 Powder for nasal administration of peptidic or proteinaceous drug

Publications (1)

Publication Number Publication Date
ATE215377T1 true ATE215377T1 (de) 2002-04-15

Family

ID=27275015

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921840T ATE215377T1 (de) 1993-07-30 1994-07-29 Pulver zur nasalen verabreichung peptidischer oder proteinischer arzneistoffe

Country Status (9)

Country Link
US (1) US5578324A (de)
EP (1) EP0667163B1 (de)
JP (1) JP2974412B2 (de)
KR (1) KR100327563B1 (de)
AT (1) ATE215377T1 (de)
CA (1) CA2145302C (de)
DE (1) DE69430295T2 (de)
ES (1) ES2171459T3 (de)
WO (1) WO1995003818A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
EP0803255A4 (de) * 1994-06-03 1999-06-30 Tsumura & Co Arzneimittel
JP3263598B2 (ja) * 1995-11-01 2002-03-04 有限会社ドット 経鼻吸収用生理活性ペプチド組成物
US6881423B2 (en) * 1996-02-27 2005-04-19 Teijin Limited Powdery composition for nasal administration
KR100611025B1 (ko) * 1998-08-26 2006-08-10 데이진 가부시키가이샤 분말상 경비 조성물
WO2003103608A2 (en) * 2002-06-11 2003-12-18 The Burnham Institute Neuroprotective synergy of erythropoietin and insulin-like growth factor
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
JP2008019245A (ja) * 2006-06-15 2008-01-31 Japan Science & Technology Agency ヒューマニン誘導体又は該誘導体と神経向性ペプチドとの融合ペプチドを有効成分として含有する、アルツハイマー病予防・治療用の経鼻投与剤
CN114288200A (zh) * 2016-11-28 2022-04-08 宝丽化成工业有限公司 皱纹改善剂
UA126100C2 (uk) * 2018-05-29 2022-08-10 Пола Кемікал Індастріз, Інк. Агент для освітлення шкіри
JP7102657B2 (ja) * 2018-05-29 2022-07-20 ポーラ化成工業株式会社 シワ改善用組成物
JP7102658B2 (ja) * 2018-05-29 2022-07-20 ポーラ化成工業株式会社 美白用組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258030A (en) * 1979-03-07 1981-03-24 Zeria-Shinyaku Kogyo Kabushiki Kaisha Urokinase preparation for oral administration
DE3514508A1 (de) * 1985-04-22 1986-10-30 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Verwendung von dopamin und dessen ester bei der behandlung von glaukom
JPH01308235A (ja) * 1988-06-03 1989-12-12 Yamanouchi Pharmaceut Co Ltd ヒト成長ホルモン経鼻剤
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
JPH04235923A (ja) * 1991-01-16 1992-08-25 Kyowa Hakko Kogyo Co Ltd 経鼻投与用製剤
JPH04300817A (ja) * 1991-03-27 1992-10-23 Shiseido Co Ltd 口腔用組成物
JPH0558908A (ja) * 1991-09-05 1993-03-09 Mitsubishi Kasei Corp カルシトニン点鼻用医薬組成物
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
JP3047948B2 (ja) * 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物

Also Published As

Publication number Publication date
EP0667163A4 (de) 2000-04-19
WO1995003818A1 (en) 1995-02-09
DE69430295T2 (de) 2002-10-31
ES2171459T3 (es) 2002-09-16
EP0667163A1 (de) 1995-08-16
DE69430295D1 (de) 2002-05-08
US5578324A (en) 1996-11-26
CA2145302A1 (en) 1995-02-09
CA2145302C (en) 2008-10-28
JP2974412B2 (ja) 1999-11-10
KR950703352A (ko) 1995-09-20
KR100327563B1 (ko) 2002-08-24
EP0667163B1 (de) 2002-04-03

Similar Documents

Publication Publication Date Title
ATE215377T1 (de) Pulver zur nasalen verabreichung peptidischer oder proteinischer arzneistoffe
AU8772691A (en) New compounds
DE69220861D1 (de) Zyklische Peptide und ihre Verwendung
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
DE69425304D1 (de) Zyklische antimikrobielle Peptide und deren Herstellung
ATE156116T1 (de) Auf aromatischen sulfonamiden basierende hydroxamsäurederivate
DK366889A (da) Peptidderivat
BR8906791A (pt) Composicao inseticida; derivado de guanidina e processo para sua preparacao
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
DE3686483D1 (de) Arzneimittel.
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
FI905575A0 (fi) Ny polypeptidfoerening och foerfarande foer dess framstaellning.
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
DK515489D0 (da) Dispergerbar laegemiddelformulering
DK0513675T3 (da) Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
ES2099828T3 (es) Derivado aminoacido.
ES8800235A1 (es) Un procedimiento para preparar un isomero sin de un compues-to de cefem
DE3464244D1 (de) 1-(4'alkylsulfonylphenyl)-2-amino-1,3-propanediol n-substituted derivatives
DK526087D0 (da) Antikonvulsive aminosyrederivater
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
IT1216104B (it) Peptidi ad attivita' farmaceutica.
GB1361198A (en) Disulphide compounds and process for their manufa'ture
EP0813866A3 (de) Therapeutisches Mittel gegen Gelenkserkrankungen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee